1.Treatment of Hepatocellular carcinoma.
Korean Journal of Medicine 2001;61(6):583-589
No abstract available.
Carcinoma, Hepatocellular*
2.Clinical evaluation of therapeutic trial for unresectable hepatocellular carcinoma.
Hung Jun KIM ; Hee Jung WANG ; Hyucksang LEE
Journal of the Korean Surgical Society 1991;40(5):601-610
No abstract available.
Carcinoma, Hepatocellular*
3.Morphometric Analysis of Cirrhotic Nodules in Hepatocellular Carcinoma-bearing Livers.
Gyeong Hoon KANG ; Yong Il KIM
Korean Journal of Pathology 1991;25(4):338-345
It has been well known that liver cirrhosis, regardless of its etiology, is an important predisposing factor in hepatocarcinogenesis. However, the type of cirrhosis in hepatocellular carcinoma(HCC)-bearing liver varies not only by geographic areas but also with the cirteria applied for morphological classification of cirrhosis. To elucidate the relationship between the nodule size of HCC-bearing cirrhotic liver and clinicopathologic features, we measured cirrhotic nodule areas of 49 surgically resected HCC cases using image analyzer. The morphological type of cirrhosis was predominantly macronodular(49%), and followed by mixed(37%) and micronodular(14%). Seventy percent of the cases showed seropositivity for HBsAg. The average area of cirrhotic nodules was significantly larger in HBsAg-positive cases(mean: 6.14 mm2) than that of HBsAg-negative cases(mean: 2.5 mm2)(p<0.05), and their size was bigger in cases with grossly expansile pattern of HCC than those cases with infiltrative ones(p<0.05). Based on the above findings, we assume that seropositivity of HBsAg may influence on the regenerative activity of cirrhotic nodules and also subsequent increase of risk for further development of HCC. The presence of cirrhohsis and nodule size seem to be the important contributing factors to determine the growing patterns of HCC.
Carcinoma, Hepatocellular
4.Hepatocellular Carcinoma.
The Korean Journal of Hepatology 2000;6(3):393-394
No abstract availalbe.
Carcinoma, Hepatocellular*
5.Small hepatocellular carcinoma; treatment with subsegmental intrahepatic arterial injection of radioliodinated fatty acid ester.
Hyung Sik YOO ; Jong Tae LEE ; Ki Whang KIM ; Chang Yun PARK ; Byung Soo KIM ; Heung Jai CHOI ; Kyong Sik LEE ; Chan Il PARK
Journal of the Korean Cancer Association 1992;24(3):411-421
No abstract available.
Carcinoma, Hepatocellular*
6.Effect of transarterial chemoembolization in postoperative recurrent hepatocellular carcinoma.
Joon Koo HAN ; Jae Hyung PARK ; Ho Chul KIM ; Hyun Kyung LEE ; Byung Ihn CHOI ; Man Chung HAN ; Dong Young NOH ; Soo Tae KIM
Journal of the Korean Radiological Society 1991;27(4):453-457
No abstract available.
Carcinoma, Hepatocellular*
7.Analysis of therapeutic effects of transarterial chemoembolization in hepatocellular carcinoma.
Myung Sook LEE ; Eun Joo AN ; Eun Chul CHUNG ; Jung Soo SUH ; Chung Sik RHEE
Journal of the Korean Radiological Society 1991;27(4):447-452
No abstract available.
Carcinoma, Hepatocellular*
8.Multicentric Occurrences of Hepatocellular Carcinoma.
The Korean Journal of Hepatology 2001;7(1):109-111
No abstract availalbe.
Carcinoma, Hepatocellular*
9.Recent advances in the management of hepatocellular carcinoma.
Journal of the Korean Medical Association 2013;56(11):946-947
No abstract available.
Carcinoma, Hepatocellular*
10.Small Hepatocellular Carcinoma: Pathologic Features of 39 Cases A Comparison with Large Hepatocellular Carcinoma.
Yong Il KIM ; Geon Kook LEE ; Sang Yong SONG
Korean Journal of Pathology 1992;26(2):103-116
With advance of diagnostic imaging technics, the detection rate of small hepatocellular carcinoma (HCC) has become much increased, but the questions whether the growth pattern and histologic nature of the HCC keep maintain the original gross and microscopic features with its advancement of tumor size remain still unclear. We reviewed 39 surgically resected hepatocellular carcinomas(HCCs) with a tumor size less than or equal to 3 cm in diameter(s-HCC), and their gross and microscopic features were compared with the HCCs bigger than 3 cm (i-HCC, 199 cases). Single nodular type(SN) was the most common gross type(60%) in s-HCCs, and was followed by single nodular type with perinodular extension(SNPE; 15.4%), multinodular-discrete type(10.3%) and multinodular-confluent type(5.1%). These figures contrasted to SNPE(42.2%) and SN(20.6%) in the i-HCCs. Of the 39 s-HCCs, 25 cases(64.1%) were encapsulated, and 14 cases(36%) demonstrated intratumoral fibrous septations, being contrasted to the i-HCCs in which fibrous septa formation was mord prominent but complete capsule formation was found only in 40.2% of the larger ones. Microscopically, the trabecular type was the most frequent one(53.9%), and increased with their size while the compact type transformed into trabecular one. Thirty three cases(84.6%) were associated with macronodular cirrhosis. Seropositivity for HBsAg was found in 26 cases(66.6%), and high serum alpha-fetoprotein level over 500 IU/L was found in 15 s-HCC cases(38.4%), while 53.3% in i-HCC. The above results suggest that HCCs change their pathologic features by increase of their size, and a comparison of the details with regard to the possible mechanisms involved is discussed.
Carcinoma, Hepatocellular